• Tumor Suppressor Gene P53 (TP53) Gene Mutation Analysis
  • Tempus PurIST℠ Pancreatic Cancer Test
  • Methylation Cancer Marker Detection in Cell-free Circulating Tumor DNA (Northstar Select and Response™)
  • Cancer Antigen (CA) 19-9, Serum
  • Niemann-Pick disease
  • The BT-Reveal Early Pancreatic Cancer Test
  • DNA Cell Cycle Analysis by Flow Cytometry
  • Tobacco use
  • OncoExTra (Oncomap™ ExTra) for Metastatic Cancer
  • Partner and Localizer of BRCA2 (PALB2) Gene Mutation Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /The BT-Reveal Early Pancreatic Cancer Test
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

The BT-Reveal Early Pancreatic Cancer Test
Medical Test

Additional ICD10
Access to The BT-Reveal Early Pancreatic Cancer Test is restricted.
Loading...